Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$656K Buy
1,863
+36
+2% +$12.8K 0.05% 228
2025
Q4
$598K Buy
1,827
+947
+108% +$300K 0.04% 234
2025
Q3
$248K Sell
880
-934
-51% -$271K 0.03% 250
2025
Q2
$507K Buy
1,814
+800
+79% +$227K 0.04% 228
2025
Q1
$316K Sell
1,014
-1,746
-63% -$516K 0.05% 216
2024
Q4
$719K Sell
2,760
-1,712
-38% -$508K 0.06% 191
2024
Q3
$1.44M Buy
4,472
+257
+6% +$84.1K 0.13% 122
2024
Q2
$1.32M Buy
4,215
+2,553
+154% +$750K 0.13% 119
2024
Q1
$471K Buy
1,662
+62
+4% +$18.1K 0.05% 222
2023
Q4
$449K Buy
+1,600
New +$436K 0.05% 211

Other funds holding AMGN

Leo Wealth LLC's AMGN Position: Q1 2026 in Review

Leo Wealth LLC increased its Amgen (AMGN) stake by 2% in Q1 2026, buying an estimated $12.8K and bringing the position to 1,863 shares worth $656K. The position accounts for 0.05% of the portfolio, ranked #228.

Leo Wealth LLC first reported a position in AMGN in Q4 2023 and has held it in 10 quarters since. The position peaked at $1.44M in Q3 2024. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Leo Wealth LLC held 1,863 shares of Amgen worth $656K as of Q1 2026.
  • Leo Wealth LLC bought 36 Amgen shares in Q1 2026, an estimated $12.8K.
  • Amgen made up 0.05% of Leo Wealth LLC's portfolio in Q1 2026, its #228 holding.
  • Leo Wealth LLC first reported a position in Amgen in Q4 2023 and has held it in 10 quarters since.
  • Leo Wealth LLC's Amgen position peaked at $1.44M in Q3 2024.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Leo Wealth LLC's 13F filing for Q1 2026, filed 5 May 2026.